GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Renergen Ltd (STU:9960) » Definitions » Cash Flow from Financing

Renergen (STU:9960) Cash Flow from Financing : €-10.11 Mil (TTM As of Feb. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Renergen Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Feb. 2025, Renergen paid €0.00 Mil more to buy back shares than it received from issuing new shares. It spent €3.49 Mil paying down its debt. It paid €0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received €0.00 Mil from paying cash dividends to shareholders. It received €5.40 Mil on other financial activities. In all, Renergen earned €1.91 Mil on financial activities for the six months ended in Feb. 2025.


Renergen Cash Flow from Financing Historical Data

The historical data trend for Renergen's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renergen Cash Flow from Financing Chart

Renergen Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only 11.96 20.10 24.56 37.72 -10.50

Renergen Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.30 15.31 22.43 -11.88 1.77

Renergen Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Renergen's Cash from Financing for the fiscal year that ended in Feb. 2024 is calculated as:

Renergen's Cash from Financing for the quarter that ended in Feb. 2025 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Feb. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-10.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renergen  (STU:9960) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Renergen's issuance of stock for the six months ended in Feb. 2025 was €0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Renergen's repurchase of stock for the six months ended in Feb. 2025 was €0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Renergen's net issuance of debt for the six months ended in Feb. 2025 was €-3.49 Mil. Renergen spent €3.49 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Renergen's net issuance of preferred for the six months ended in Feb. 2025 was €0.00 Mil. Renergen paid €0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Renergen's cash flow for dividends for the six months ended in Feb. 2025 was €0.00 Mil. Renergen received €0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Renergen's other financing for the six months ended in Feb. 2025 was €5.40 Mil. Renergen received €5.40 Mil on other financial activities.


Renergen Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Renergen's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Renergen Business Description

Industry
Traded in Other Exchanges
Address
25 Minerva Avenue, Sandton Gate, Glenadrienne, Sandton, ZAF, 2196
Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.

Renergen Headlines

No Headlines